Acute diffuse interstitial nephritis related to chemotherapy of tuberculosis. 1976

W J Stone, and J A Waldron, and J H Dixon, and R K primm, and R G Horn

Acute renal insufficiency developed in three patients receiving chemotherapy for tuberculosis. It is proposed that acute diffuse interstitial nephritis related to the drugs was responsible for the renal injury. Recovery of renal function was slow and incomplete. Physicians administering chemotherapy to patients with tuberculosis must be aware of the potential nephrotoxicity of the common treatment regimens.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009395 Nephritis, Interstitial Inflammation of the interstitial tissue of the kidney. This term is generally used for primary inflammation of KIDNEY TUBULES and/or surrounding interstitium. For primary inflammation of glomerular interstitium, see GLOMERULONEPHRITIS. Infiltration of the inflammatory cells into the interstitial compartment results in EDEMA, increased spaces between the tubules, and tubular renal dysfunction. Interstitial Nephritis,Nephritis, Tubulointerstitial,Tubulointerstitial Nephritis,Interstitial Nephritides,Nephritides, Interstitial,Nephritides, Tubulointerstitial,Tubulointerstitial Nephritides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses

Related Publications

W J Stone, and J A Waldron, and J H Dixon, and R K primm, and R G Horn
April 2008, JPMA. The Journal of the Pakistan Medical Association,
W J Stone, and J A Waldron, and J H Dixon, and R K primm, and R G Horn
October 1980, Gastroenterology,
W J Stone, and J A Waldron, and J H Dixon, and R K primm, and R G Horn
April 1999, Clinical nephrology,
W J Stone, and J A Waldron, and J H Dixon, and R K primm, and R G Horn
April 1969, Pediatrics,
W J Stone, and J A Waldron, and J H Dixon, and R K primm, and R G Horn
October 2022, Postgraduate medical journal,
W J Stone, and J A Waldron, and J H Dixon, and R K primm, and R G Horn
December 2016, British journal of cancer,
W J Stone, and J A Waldron, and J H Dixon, and R K primm, and R G Horn
April 1968, The American journal of medicine,
W J Stone, and J A Waldron, and J H Dixon, and R K primm, and R G Horn
April 2013, Current drug safety,
W J Stone, and J A Waldron, and J H Dixon, and R K primm, and R G Horn
June 2010, Kidney international,
W J Stone, and J A Waldron, and J H Dixon, and R K primm, and R G Horn
May 1898, Journal. Boston Society of Medical Sciences,
Copied contents to your clipboard!